CIK 0001235912 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
CVRx, Inc.
Sign in to watch- Ticker
- CVRX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 7634162850
- Business address
- 9201 WEST BROADWAY AVENUE, SUITE 650, MINNEAPOLIS, MN, 55445
- Former names
- CVRX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Morrison Gregory CHIEF HUMAN RESOURCES OFFICER | Grant or award · Stock Option (right to buy) | +154,500 | 154,500 | ||
| 2026-03-02 | John Robert Allen Chief Revenue Officer | Sale 10b5-1 | −3,964 | $7.90 | $31K | 86,036 |
| 2026-03-02 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Sale 10b5-1 | −1,284 | $7.90 | $10K | 60,551 |
| 2026-03-02 | OASHEIM JARED CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,744 | $7.90 | $14K | 96,703 |
| 2026-03-02 | Hykes Kevin PRES & CEO | Sale 10b5-1 | −7,763 | $7.90 | $61K | 284,237 |
| 2026-02-27 | Adamson Philip B. Chief Medical Officer | Grant or award 10b5-1 | +41,000 | 62,840 | ||
| 2026-02-27 | Adamson Philip B. Chief Medical Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +62,000 | 62,000 | ||
| 2026-02-27 | John Robert Allen Chief Revenue Officer | Grant or award 10b5-1 | +35,000 | 90,000 | ||
| 2026-02-27 | John Robert Allen Chief Revenue Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +52,000 | 52,000 | ||
| 2026-02-27 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Grant or award 10b5-1 | +45,000 | 61,835 | ||
| 2026-02-27 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Grant or award · Stock Option (right to buy) 10b5-1 | +67,000 | 67,000 | ||
| 2026-02-27 | OASHEIM JARED CHIEF FINANCIAL OFFICER | Grant or award 10b5-1 | +61,000 | 98,447 | ||
| 2026-02-27 | OASHEIM JARED CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) 10b5-1 | +91,000 | 91,000 | ||
| 2026-02-27 | Binkowski Brent CHIEF OPERATING OFFICER | Grant or award | +15,000 | 31,600 | ||
| 2026-02-27 | Binkowski Brent CHIEF OPERATING OFFICER | Grant or award · Stock Option (right to buy) | +23,000 | 23,000 | ||
| 2026-02-27 | Hykes Kevin PRES & CEO | Grant or award 10b5-1 | +159,000 | 292,000 | ||
| 2026-02-27 | Hykes Kevin PRES & CEO | Grant or award · Stock Option (right to buy) 10b5-1 | +238,000 | 238,000 | ||
| 2026-02-20 | Jain Mudit K. Director | Purchase | +46,800 | $6.36 | $298K | 980,183 |
| 2026-02-18 | Jain Mudit K. Director | Purchase | +600 | $4.64 | $3K | 5,650 |
| 2025-11-26 | JOHNSON & JOHNSON 10% owner | Sale | −6,337 | $10.03 | $64K | 4,024,861 |
Page 2 of 22 · 422 trades